Accumin Diagnostics Inc entered the industry of Medical Labs in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 3254120, which describes it as a Medical Labs. For further clarification, the SIC classifies this business under the code 8071 and described it as a Medical Labs. The business provides service to the B2C market.
To acquire more information, please contact Ken Hobiman by calling (212) 531-5965 during business hours. You can also write to the business’ Single Location at 750 Lexington Avenue Floor 20, New York City, New York NY 10022. You can also visit the company’s website at keryx.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Accumin Diagnostics Inc |
| Representative: | Ken Hobiman |
| Place of Business: | 750 Lexington Avenue Floor 20, New York City, NY 10022 |
| Contact Number: | (212) 531-5965 |
| Website: | keryx.com |
| Type of Service: | Medical Labs |
| SIC Number: | 8071 |
| NAICS Number: | 3254120 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2010 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Accumin Diagnostics Inc is a company operating from New York, New York providing professional Medical Labs and relevant B2C variables. It was founded in 2010 and registered with the SIC code 8071 as Medical Labs, and with the NAICS code 3254120 as Medical Labs.
With a current employee count of 1 to 4, Accumin Diagnostics Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Ken Hobiman at (212) 531-5965 for related queries, or to locate its Single Location using the coordinates 40.762509,-73.968061.
The Single Location can also be found at the street address 750 Lexington Avenue Floor 20 in New York City, New York 10022 and can be engaged online through the company website at keryx.com, the company Twitter , and Facebook page .